Select your country

Africa
Asia
Europe
Latin America
North America
Oceania

Merck KGaA, Darmstadt, Germany, Response on European Commission Statement of Objections

Merck KGaA, Darmstadt, Germany, today confirmed receipt of a Statement of Objections from the European Commission (EC) related to a packaging technology in development by Sigma-Aldrich.

06 Jul 2017 | Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, today confirmed receipt of a Statement of Objections from the European Commission (EC) related to a packaging technology in development by Sigma-Aldrich, at the time it was acquired by Merck KGaA, Darmstadt, Germany, in 2015. Merck KGaA, Darmstadt, Germany, will review the information provided by the EC and provide its written response to the EC in due course. Merck KGaA, Darmstadt, Germany, has acted in good faith since the anti-trust process has begun, and it is committed to a constructive dialogue with the EC. Merck KGaA, Darmstadt, Germany, is confident this issue will be resolved in a satisfactory manner. As this process is ongoing, Merck KGaA, Darmstadt, Germany, has no further comment at this time.

Downloads

For more information, contact Markus Talanow

All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck KGaA, Darmstadt, Germany, generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the Merck KGaA, Darmstadt, Germany, name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Related News

Press Releases

Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent for ...

Merck KGaA, Darmstadt, Germany, today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases.

2018/08/15

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement